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Introduction
In utero exposure of rats to high doses of 
certain phthalate esters, such as diethylhexyl 
phthalate (DEHP) or di(n-butyl) phthalate 
(DBP), impairs steroido genesis by the fetal 
testis, resulting in post natal disorders such as 
hypospadias, cryptorchidism, and impaired 
spermato genesis (Drake et al. 2009; Johnson 
et al. 2012; Lehmann et al. 2004; Thompson 
et al. 2004). In humans, these disorders are 
thought to comprise a “testicular dysgenesis 
syndrome” (TDS) (Skakkebaek et al. 2001), 
for which the DBP-exposed Wistar rat may 
be a useful model to dissect the underlying 
mechanisms (Fisher et al. 2003; Sharpe and 
Skakkebaek 2008). However, in contrast to 
the inhibitory effects of DBP exposure on the 
fetal rat testis, the human fetal testis appears 
to be insensitive to the steroidogenic effects 
of DBP based on studies involving in vitro 
and xenograft models (Albert and Jégou 
2014; Heger et al. 2012; Lambrot et al. 2009; 
Mitchell et al. 2012; Spade et al. 2014).
DEHP/DBP exposure also induces germ 
cell effects in the fetal rat testis, namely, induc-
tion of multi nucleated gonocytes (MNGs) 
(Ferrara et al. 2006; Mylchreest et al. 2002; 
Parks et al. 2000) and aggregation of germ cells 
in the seminiferous cords (Barlow and Foster 
2003; Kleymenova et al. 2005). These changes 
are evident only from embryonic day (E) 19.5 
to E21.5 in the rat, and are thus confined to 
differentiated germ cells [i.e., no octamer-
binding transcription factor 3/4 (OCT3/4) 
expression) (Ferrara et al. 2006; Jobling 
et al. 2011). Indirect evidence (Jobling et al. 
2011; Kleymenova et al. 2005) suggests that 
these germ cell changes may be secondary to 
effects on Sertoli cells. However, DEHP/DBP 
exposure also induces a reduction in germ cell 
number that is divorced temporally from aggre-
gation. This effect is confined to the period 
in the rat when germ cells are undifferenti-
ated (expressing OCT3/4) and proliferating, 
namely, E13.5–E17.5 (Jobling et al. 2011), 
and can cause up to 40% reduction in germ 
cell number by birth (Jobling et al. 2011).
DEHP/MEHP induces germ cell loss 
and MNGs in vitro using human fetal testis 
explants (Chauvigné et al. 2009; Habert et al. 
2009; Lambrot et al. 2009; Lehraiki et al. 
2009; Muczynski et al. 2012), and DBP 
exposure induces MNGs in human fetal testis 
xenografts (Heger et al. 2012). However, 
none of these studies determined whether the 
phthalate effects were dependent on the stage 
of germ cell differentiation, which appears to 
be critical in vivo in rats.
In the present study we sought to 
a) compare the effects of DBP exposure on 
germ cell aggregation and MNG induction 
in the rat and in an established human fetal 
testis xenograft model (Mitchell et al. 2010, 
2012); b) determine whether these changes 
result from impaired Sertoli–germ cell inter-
action at the membrane level; c) establish 
whether DBP-induced germ cell loss occurs 
in the human fetal testis xenograft model; and 
d) determine whether effects are restricted to 
the undifferentiated germ cell population. By 
answering these questions, we could identify 
the potential effects of phthalate exposure 
on fetal human germ cells and establish 
that the rat may be an appropriate model 
for investigating underlying mechanisms 
(and their consequences). This is important, 
considering the disparity in phthalate effects 
on fetal testis steroidogenesis in the rat and 
human and that fetal germ cells ultimately 
give rise to the next generation. Fetal germ 
cells are also believed to be the cell of origin 
for testicular germ cell cancers in young men 
(Rajpert-De Meyts 2006).
Materials and Methods
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Background: Phthalate exposure induces germ cell effects in the fetal rat testis. Although 
experimental models have shown that the human fetal testis is insensitive to the steroidogenic 
effects of phthalates, the effects on germ cells have been less explored.
oBjectives: We sought to identify the effects of phthalate exposure on human fetal germ cells 
in a dynamic model and to establish whether the rat is an appropriate model for investigating 
such effects.
Methods: We used immunohistochemistry, immunofluorescence, and quantitative real-time 
polymerase chain reaction to examine Sertoli and germ cell markers on rat testes and human fetal 
testis xenografts after exposure to vehicle or di(n-butyl) phthalate (DBP). Our study included 
analysis of germ cell differentiation markers, proliferation markers, and cell adhesion proteins.
results: In both rat and human fetal testes, DBP exposure induced similar germ cell effects, 
namely, germ cell loss (predominantly undifferentiated), induction of multinucleated gonocytes 
(MNGs), and aggregation of differentiated germ cells, although the latter occurred rarely in the 
human testes. The mechanism for germ cell aggregation and MNG induction appears to be loss of 
Sertoli cell–germ cell membrane adhesion, probably due to Sertoli cell microfilament redistribution. 
conclusions: Our findings provide the first comparison of DBP effects on germ cell number, 
differentiation, and aggregation in human testis xenografts and in vivo in rats. We observed 
comparable effects on germ cells in both species, but the effects in the human were muted compared 
with those in the rat. Nevertheless, phthalate effects on germ cells have potential implications 
for the next generation, which merits further study. Our results indicate that the rat is a human-
relevant model in which to explore the mechanisms for germ cell effects.
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the Lothian Research Ethics Committee 
(LREC-08/S1101/1).
DBP treatment of rats. Wistar rats 
(Harlan, Derby, UK) were housed in 
ventilated cages (2000P cages; Tecniplast, 
Buguggiate, Italy) with 4–6 adult female rats 
per cage, and had ad libitum access to sterile 
water and a soy-free breeding diet [RM3(E); 
SDS, Dundee, Scotland]. We carefully 
controlled housing conditions: lights on at 
0700 and off at 1900 hours; temperature, 
19–21°C; humidity, 45–65%; GOLD 
shavings and LITASPEN standard bedding 
(SPPS, Argenteuil, France). Animals were 
housed for a minimum of 2 weeks prior to 
use in experimental studies. We randomly 
allocated time-mated females to receive either 
0 (control), 4, 20, 100, or 500 mg/kg DBP 
(99% pure; Sigma-Aldrich, Dorset, UK) 
in 1 mL/kg corn oil daily by oral gavage. 
Treatments were adminis tered between 0900 
and 1030 hours, commencing on E13.5 
until the day prior to culling (or as indicated 
otherwise). All treatments were performed in 
a single animal facility at the University of 
Edinburgh. The weight of the female rats prior 
to the start of treatment was 266.4–319.8 g, 
and we observed no generalized adverse 
effects of the exposure to DBP. There was no 
significant effect of the treatment on litter size 
or sex ratio. We sampled male offspring on 
E17.5, E21.5, or postnatal day (PND) 4—
time points chosen to reflect the period 
before, during, and after the appearance of 
DBP-induced MNGs and gonocyte aggrega-
tion. We used 12–14 animals from three to 
five litters per exposure group, and all experi-
ments reported included animals from each 
of these litters. Pregnant dams were killed by 
CO2 inhalation followed by cervical disloca-
tion. Fetuses were removed, decapitated, and 
placed in ice-cold phosphate-buffered saline 
(PBS; Sigma-Aldrich). PND4 pups were 
housed with their natural mothers from birth 
and were killed by cervical dislocation. Fetuses 
and pups were transported immediately to the 
laboratory, and testes were removed by micro-
dissection. Embryonic testes were fixed for 
1 hr in Bouin’s fixative (3 hr for PND4 testes) 
then transferred to 70% ethanol. We used 
representative fetuses for the quantitative and 
immuno histochemical experiments. For each 
E21.5 fetus, one testis was fixed as described 
above, and the other testis was snap frozen and 
stored at –70°C for gene expression analysis.
Human fetal testis xenografts. Male 
CD1 nude mice (Charles River, Margate, 
UK) were used as host mice for human fetal 
testis xenografts. Mice were housed in indi-
vidually ventilated cages with free access to 
sterile food and water. Human fetal testis 
tissue (collected at 14–20 weeks; n = 7) was 
xenografted subcutaneously into host mice 
as previously described (Mitchell et al. 2010, 
2012). Host mice carrying human fetal testes 
xenografts (5–6 per mouse) were subcu-
taneously injected every 72 hr (three times 
per week) with human chorionic gonado-
tropin (hCG) (20 IU, Pregnyl; Organon 
Laboratories, Cambridge, UK) in 0.9% 
(wt/vol) saline containing 1% (vol/vol) fetal 
bovine serum in order to mimic the normal 
in utero environ ment. We then treated host 
mice with vehicle or 500 mg/kg/day DBP for 
21 days as described previously (Mitchell et al. 
2012). We fixed xenografts in Bouin’s fixative 
for 1 hr, transferred them to 70% ethanol, 
and processed them into paraffin blocks using 
standard procedures.
Immunohi s tochemis t ry .  We used 
immuno histo chemistry for VASA [DEAD 
(Asp-Glu-Ala-Asp) box poly peptide 4/mouse 
VASA homologue; DDX4/MVH] to identify 
germ cells in rat testes for analysis of aggre-
gation using image analysis. Similarly, we 
performed immuno histochemistry for 
MAGE-A4 (melanoma antigen family A, 4; 
expressed only in differen tiated germ cells) 
and anti-Müllerian hormone (AMH; in 
Sertoli cells) on human fetal testis xenograft 
sections. Antibodies and detection reagents 
are listed in Table 1. For each experiment, we 
included a negative control (primary antibody 
replaced with appropriate normal serum). We 
used protocols described previously (Jobling 
et al. 2011; McKinnell et al. 2013; Mitchell 
et al. 2010; van den Driesche et al. 2012).
D o u b l e  i m m u n o f l u o r e s c e n c e  f o r 
adenomatous polyposis coli (APC)/espin, 
vimentin/N‑cadherin, and APC/N‑cadherin. 
To determine whether germ cell aggregation 
in rats resulted from impaired Sertoli–germ 
cell inter action at the cell membrane, we 
performed double fluorescence immuno-
histo chemistry for N-cadherin plus vimentin 
and for APC plus espin; results were analyzed 
using confocal laser scanning microscopy. We 
costained vehicle- and DBP-exposed human 
fetal testis xenograft sections for N-cadherin 
and APC using previously described proce-
dures (Jobling et al. 2011; McKinnell et al. 
2013). Antibodies and detection reagents are 
listed in Table 1. 
Triple immunofluorescence for OCT3/4, 
MAGE‑A4, and Ki67. To investigate whether 
DBP exposure of human fetal testis xenografts 
affected germ cell number or proliferation, 
we undertook triple fluorescence immuno-
histochemistry for the undifferentiated 
(pluripotent) germ cell marker OCT3/4, the 
differentiated germ cell marker MAGE-A4, 
and the proliferation marker Ki67, as 
described previously (Mitchell et al. 2010). 
Antibodies and reagents are listed in Table 1.
Measurement of germ cell aggregation in 
rat testes. Because all germ cells in the peri natal 
rat testis immunostain intensely for VASA 
in the cytoplasm, we were able to use VASA 
immuno histo chemistry to develop an objective 
method for measuring germ cell aggregation, 
based on average germ cell cluster size, in testes 
from control and DBP-exposed rats at E17.5, 
E21.5, and PND4. We used stereological 
methods adapted from previous studies to 
evaluate fetal Leydig cell aggregation (Mahood 
et al. 2005, 2007) using sections from at 
least five fetuses from three to five litters. In 
E21.5 controls, germ cells were in clusters 
that varied in size from < 20 to 2,800 arbi-
trary units (AU), with most sized < 1,000 AU 
(Figure 1A). In E21.5 DBP-exposed animals, 
clusters were fewer and, on average, 15% 
of seminiferous cords contained clusters 
> 3,000 AU, a size rare in controls (Figure 1A). 
A cutoff of > 3,000 AU discriminated best 
between control and DBP-exposed animals 
at E21.5 and was therefore used for all aggre-
gation analyses. For determination of germ 
cell number at E21.5 after in utero exposure 
to DBP from E13.5–E15.5 or E19.5–E20.5, 
we also used VASA staining and stereology as 
described by Jobling et al. (2011).
Table 1. Antibodies used for immunohistochemistry and immunofluorescence. 
Primary antibody Source Dilution
Secondary 
antibody Visualization
Melanoma-associated antigen 4 (MAGE-A4; IHC) Gifta 1:20 GAM-bb DABc
VASA [DEAD (Asp-Glu-Ala-Asp) box polypeptide 
4 (DDX4); mouse VASA homologue (MVH)]
Abcam 1:80 GAR-bb DABc
Anti-Müllerian hormone (AMH) Santa Cruz Biotechnology 1:500 RAG-bb DABc
Adenomatous polyposis coli (APC) Fisher Scientific 1:750 GAR-pb Tyr-fld
Espin BD Transduction Labs 1:4,000 GAM-pb Tyr-Cy3
N-Cadherin Zymed Laboratories 1:4,000 GAM-pb Tyr-fld
Vimentin DAKO 1:750 GAM-pb Tyr-Cy3d
MAGE-A4 (IF) Gifta 1:100 ChAM-pb Tyr-Cy5d
Octamer-binding transcription factor 3/4 (OCT3/4) Santa Cruz Biotechnology 1:100 ChAG-pb Tyr-Cy3d
Ki67 DAKO 1:200 ChAM-pb Tyr-fld
Abbreviations: ChAG-p, chicken anti-goat peroxidase; ChAM-p, chicken anti-mouse peroxidase; DAB, 3,3´-diamino-
benzidine tetrahydrochloride; GAM-b, goat anti-mouse biotin; GAM-p, goat anti-mouse peroxidase; GAR-b, goat 
anti-rabbit biotin; GAR-p, goat anti-rabbit peroxidase; IHC, immunohisto chemistry; IF, immunofluorescence; MAGE-4, 
melanoma antigen family A, 4; RAG-b, rabbit anti-goat biotin; Tyr-Cy3, tyramide Cy3; Tyr-Cy5, tyramide Cy5; Tyr-fl, 
tyramide fluorescein.
aGift from G. Spagnoli, University Hospital, Basel, Switzerland. bDAKO (Ely, Cambridgeshire, UK). cVector Labs 
(Peterborough, UK). dPerkinElmer (Billerica, MA, USA). 
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Quantification of MNGs in human fetal 
testis xenografts and fetal rat testes. AMH is 
expressed in Sertoli cell cytoplasm but not in 
germ cells, so we used AMH immuno staining 
to facilitate identification of germ cells and 
MNGs, and to quantify the frequency of 
MNGs in human fetal testis xenografts and in 
E21.5 fetal rat testes. We analyzed two sections 
per xenograft and one complete testis cross 
section for fetal rats using an Axio-Imager 
microscope (Carl Zeiss Ltd, Cambridge, 
UK) fitted with a Hitachi HV-C20 camera 
(Hitachi Denshi Europe, Leeds, UK) and 
a Prior automatic stage (Prior Scientific 
Instruments Ltd., Cambridge, UK). We used 
Image-Pro 6.2 software with the Stereologer 
plug-in (MagWorldwide, Wokingham, UK) to 
select random fields within the tissue (15–25 
fields per section). All germ cells and MNGs 
in each field were counted separately using 
the Stereologer manual tagging function, and 
the prevalence of MNGs was calculated as a 
percentage of the total counted (≥ 350 germ 
cells plus MNGs per section).
Quantification of germ cell differentiation 
and proliferation in human fetal testis xeno‑
grafts. We generated high-resolution, tiled 
confocal scanning laser microscopy images of 
complete human fetal testis xenograft sections 
costained for OCT3/4, MAGE-A4, and Ki67 
and then quantified germ cell subpopulations 
and proliferation indices. We counted all germ 
cells within each section according to their 
protein expression profile and prolifera tion 
status using Zen 2011 software (Carl Zeiss 
Ltd.). Each xenografted testis was implanted 
into two to four recipient mice for each 
treatment. We determined germ cell number 
and differen tiation status for each xenograft; 
we then compiled the average germ cell 
number per treatment and fetus. The total 
number of germ cells counted ranged from 43 
to 457 in different xenografts.
Image capture. We examined and photo-
graphed non fluorescent images using a 
Provis AX70 microscope (Olympus Optical, 
London, UK) fitted with a Canon DS6031 
Figure 1. (A) Analysis of the number and size of germ cell aggregates for a representative control rat (left) and a DBP-exposed rat (right) at E21.5. The dashed 
lines indicate clusters > 3,000 AU, the arbitrary cut-off point; note the different scales used for vehicle and DBP exposure. (B) Dose dependence of DBP-induced 
germ cell aggregation at E21.5. Unless otherwise indicated, exposure took place daily on E13.5–16.5 (E17.5), E13.5–20.5 (E21.5), or E13.5–21.5 (PND4). Values 
shown are mean ± SE of 5 animals (representing 5 litters) per exposure group. Data were analyzed by one-way ANOVA followed by Bonferroni post hoc test. 
**p < 0.01, and #p < 0.001, compared with the respective control. 
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Figure 2. Germ cell (GC) distribution and GC aggregation in the rat at E17.5, E21.5, and PND4 after exposure 
to vehicle (control; A–C) or DBP at 500 mg/kg (D–F) and in human fetal testis xenografts after exposure to 
vehicle (G,J) or 500 mg/kg DBP (H,I,K,L). (A–F) Distribution of GCs visualized by immuno staining for VASA 
(DDX4/MVH); at E21.5, GC aggregation (asterisks) was present in testes of DBP-exposed animals (E), but 
GC distribution was normal in testes from vehicle-exposed animals (B). (G–L) Consecutive sections of 
human fetal testis xenografts from vehicle- and DBP-exposed hosts immuno stained for MAGE-A4 (G–I) or 
AMH (J–L). Note that GC aggregations were found in only 4 of 54 DBP-exposed xenografts, all from one 
fetus. Bars = 50 μm (A–F) and 100 μm (G–L). 
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digital camera (Canon Europe, Amsterdam, 
the Netherlands). We captured all fluores-
cent images using a Zeiss LSM 710 confocal 
microscope (Carl Zeiss Ltd.). We compiled 
images using Adobe Photoshop v12 (Adobe, 
San Jose, CA, USA).
Gene expression analysis in E21.5 rat fetal 
testes samples. For quantitative analysis of gene 
expression, we extracted and used total RNA 
from E21.5 testes to prepare random hexamer-
primed cDNA (van den Driesche et al. 
2012). We performed quantitative real-time 
polymerase chain reaction (qRT-PCR) using 
the ABI Prism Sequence Detection System 
(Applied Biosystems, Grand Island, NY, USA). 
We determined the expression of rat Apc, Espn 
(espin), Cdh2 (cadherin 2), and Vim (vimentin) 
mRNA using the Roche Universal Probe 
Library (Roche Applied Sciences, Burgess Hill, 
UK) [Apc forward primer: 5´-CTTC GTGT 
ACGG CAGC TCTT-3´, reverse primer: 
5´-GCAG TTTC ATGC TTGC TCTG-3´ 
(probe 127, catalog no. 04693639001); Espn 
forward primer: 5´-CACC CTCT CCAA CTAT 
GACT CC-3´, reverse primer 5´-GCTC TGTA 
AGTC TGAG GATC TGG-3´, probe 25, 
catalog no. 04686993001; Cdh2 forward 
primer: 5´-TGTT CCAG AGGG ATCA 
AAGC-3´, reverse primer: 5´-GAGA GGAT 
CCTG TACC TCAG CA-3´, probe 122, 
catalog no. 04693566001; Vim forward primer: 
5´-CAGG AAGC TGCT GGAA GG-3´, reverse 
primer: 5´-GGAA GTGA CTCC AGGT 
TAGT TTCT-3´, probe 108, catalog no. 
04692276001. We corrected expression of each 
gene using a ribosomal 18S internal control 
(catalog no. 4308329; Applied Biosystems). 
We analyzed all samples in triplicate and made 
relative comparison to adult testis control 
cDNA using the ddCt method. We analyzed 
12 animals for the control group (from three 
litters) and 14 animals for the 500 mg/kg/day 
DBP group (from five litters). 
Statistical analysis. Most of the rat data 
was derived from one animal per litter and 
was thus analyzed using either Student’s t-test 
or one-way analysis of variance (ANOVA) 
followed by the Bonferroni post hoc test; for 
experiments in which several animals were 
used per litter (mRNA expression analysis), 
we accounted for within-litter effects using 
two-factor ANOVA. We analyzed human 
fetal testis xenograft experiments using the 
paired t-test (MNG analysis) or two-way 
ANOVA (germ cell counts), the latter to 
take into account within-fetus effects. We 
performed analyses using GraphPad Prism 5 
(GraphPad Software Inc., La Jolla, CA, USA). 
Results
Germ cell aggregation in fetal rat testes and 
human fetal testis xenografts. DBP-induced 
rat germ cell aggregation was evident at E21.5 
but largely resolved by PND4 (Figure 2A–F), 
findings we confirmed quantitatively 
(Figure 1B). Unexpectedly, E17.5 germ cells 
appeared to be aggregated in both control 
and DBP-exposed animals (Figure 2A,D). 
However, whereas these germ cell aggregates 
underwent “disaggregation” in controls 
between E17.5 and E21.5, this process 
failed to occur by E21.5 in DBP-exposed 
animals (Figure 2E). We evaluated the dose 
dependence of DBP-induced germ cell 
aggregation at E21.5 and found that aggrega-
tion was induced by exposure to DBP at all 
doses of ≥ 20 mg/kg (Figure 1B).
Using xenograft sections immuno stained 
for MAGE-A4 (Figure 2G–I) or for OCT3/4 
(not shown), we found germ cell aggregation 
in only 4 of 54 DBP-exposed xenografts from 
seven fetuses, and these 4 xenografts were 
Figure 3. Effect of exposure to vehicle or DBP (500 mg/kg/day) on Sertoli–germ cell interactions in fetal 
rat testes at E17.5 and E21.5 (A–H) and in human fetal testis xenografts (I,J). Representative photomicro-
graphs of fetal rat testes on E17.5 and E21.5 show immuno expression of APC (green) in germ cells and 
espin (red) in Sertoli cells (A–D), and vimentin (red) and N-cadherin (green) in Sertoli cells (E–H). (I,J) APC 
(red) and N-cadherin (green) immunoexpression were evaluated in xenografts from hosts treated with 
vehicle (I) and DBP (J). Insets, higher magnification of seminiferous cords. In rats, yellow staining (APC 
and espin colocalization; white arrows) was absent in DBP-exposed samples at all ages (C–D) compared 
with vehicle-exposed controls (A–B). Similarly, vimentin and N-cadherin costaining demonstrated a lack 
of apical Sertoli cell cytoplasmic extensions after DBP exposure (yellow arrows) in rats, indicative of 
withdrawal of Sertoli cell cytoplasm from around and between the germ cells (E–H). Similar loss of Sertoli-
germ cell membrane interaction was observed in the limited human fetal testis xenografts that exhibited 
germ cell aggregation after exposure to DBP (J). White asterisks indicate normal germ cells, and yellow 
asterisks indicate abnormal germ cell aggregation. In rats, treatment was administered daily from E13.5 
until the day before sampling (E17.5 or E21.5). Bars = 50 μm. 
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all derived from a single fetus (Figure 2H). 
The remaining 50 DBP-exposed xenografts 
were indistinguishable from vehicle-exposed 
xenografts (Figure 2G,I). We confirmed 
this by immuno staining for the Sertoli cell 
marker AMH (Figure 2J–L). We concluded 
that DBP-exposure resulted only in sporadic 
germ cell aggregation in xenografted human 
testes, but when aggregation was induced, it 
affected differen tiated [MAGE-A4–positive 
(MAGE-A4pos)] germ cells, as in rats. 
Sertoli–germ cell interaction. To study 
the role of Sertoli–germ cell interactions in 
DBP-induced germ cell aggregation, we 
examined expression of cell–cell adhesion 
molecules, APC, espin, vimentin, and 
N-cadherin (Bartles et al. 1996; Chen et al. 
1999; Ivaska et al. 2007; Kleymenova et al. 
2005; Strelkov et al. 2003; Tanwar et al. 2011; 
Vogl et al. 2008). In control rats at E17.5 and 
E21.5, espin was expressed in distal Sertoli 
cell cytoplasm that extended into “fingers” 
that encircled each germ cell (Figure 3A,B). 
APC expression was restricted to germ cells 
but colocalized with espin (expressed in 
Sertoli cells) where Sertoli and germ cells 
were apposed (visible as yellow staining in 
insets of Figure 3A,B); we interpreted this as 
evidence for Sertoli–germ cell interaction at 
the membrane level, and it was evident at all 
ages in controls. In contrast, in DBP-exposed 
rats at E17.5 and E21.5, Sertoli cell cytoplasm 
was not evident between the germ cells, and 
there was no over lapping of espin and APC 
expression (Figure 3C,D), indicative of the 
absence of direct Sertoli–germ cell membrane 
contact, coincident with germ cell aggregation. 
However, by PND4, Sertoli cell espin expres-
sion in testes of DBP-exposed rats was largely 
restored to normal, with cytoplasmic “fingers” 
extending around individual germ cells and 
interacting with APC at the membrane 
level, as in controls (data not shown). 
Immunostaining for the Sertoli cell filaments 
vimentin and N-cadherin showed that the 
former was confined to basal and the latter to 
apical Sertoli cell cytoplasm, but both showed 
evidence for retraction in DBP-exposed rats, 
similar to that found for espin (Figure 3E–H). 
Because mRNA expression for Apc, Espn, 
Cdh2, and Vim was unchanged at E21.5 after 
DBP exposure (Figure 4), we presume that 
the DBP-induced micro filament changes 
resulted from protein redistribution, although 
DBP-induced protein degradation and/or 
translational regulation cannot be excluded.
Immunostaining for APC and N-cadherin 
in control human fetal testis xenografts 
demonstrated Sertoli cell cytoplasm distri-
bution around the germ cells (Figure 3I,J), 
similar to that in rats. However in the few 
seminiferous cords that exhibited germ cell 
aggregation after exposure to DBP, there was 
a lack of Sertoli cell cytoplasmic “fingers” 
extending around the germ cells, again 
comparable to the findings in rats.
MNGs in E21.5 rat testes and in human 
fetal testis xenografts after exposure to DBP. 
We used AMH-stained sections in which 
germ cells remained unstained to determine 
the appearance of MNGs in fetal rat testes 
and human fetal testis xenografts after DBP 
exposure. In E21.5 testes from DBP-exposed 
rats, we observed a significant increase in 
MNGs (expressed as a percentage of all germ 
cells) compared with the vehicle-exposed 
group (controls 0%; DBP 3.9%, p = 0.0016; 
Figure 5A–C). In human fetal testis xeno-
grafts, we observed a low frequency (0.8%) 
of MNGs in vehicle-exposed controls, similar 
to that described by Heger et al. (2012). We 
also observed a significant increase in inci-
dence (1.76%) of MNGs in xenografts from 
DBP-exposed animals compared with vehicle-
exposed animals (p = 0.0034; Figure 5D–F).
Effects of DBP on germ cell prolifera‑
tion and number in human fetal testis xeno‑
grafts and on germ cell number in fetal rat 
testes. We triple immunostained xenografts 
for OCT3/4 (undifferentiated germ cell 
marker), MAGE-A4 (differentiated germ 
cell marker), and the prolifera tion marker 
Ki67 (Figure 6A–D). For vehicle- and 
DBP-exposed xenografts, the majority of 
undifferentiated germ cells were immuno-
positive for Ki67, indicating active prolifera-
tion, whereas Ki67pos/MAGE-A4pos germ cells 
were rare (Figure 6E), indicating that germ 
cells stopped proliferating after differentiation. 
In rats, exposure to DBP only on E13.5–
E15.5 (when germ cells express OCT3/4 
and proliferate) reduced the number of 
germ cells at E21.5, whereas DBP exposure 
on E19.5–E20.5 (when germ cells have 
differentiated and stopped proliferating) 
had no significant effect (Figure 7A). In 
human fetal testis xenografts, we observed 
a small but significant reduction in the 
total number of germ cells per xenograft 
as a result of DBP exposure (Figure 7B). 
Similar to the fetal rat, DBP-exposure in 
human fetal testis xenografts resulted in 
Figure 5. Effect of exposure to vehicle or DBP (500 mg/kg/day) on the induction of multinucleated gono-
cytes (MNGs) in rat testes at E21.5 (A–C) and in human fetal testis xenografts (D–F). AMH immuno staining 
(brown) highlights an increased number of MNGs (arrows) in both rat (B) and human (E) fetal testis 
samples after DBP exposure; these results were confirmed by quantification (C,F). MNG quantification 
in rat testis (C) represents 4 control animals and 4 DBP-exposed animals, with one section per testis 
analyzed. For xenografts (F), two sections were quantified from 1–5 grafts from seven different fetuses 
(numbered 1–7); p = 0.0034 for DBP exposure compared with vehicle. For A–E, bars = 100 μm. 
**p < 0.01 compared with the respective vehicle group.
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a significant reduction (p = 0.041) in the 
number of OCT3/4pos germ cells compared 
with vehicle exposure (Figure 7C), whereas 
there was a non significant reduction in 
the number of MAGE-A4pos germ cells 
(p = 0.057; Figure 7D). Thus, DBP exposure 
resulted in germ cell loss in the human testis 
during the developmental stage examined 
(14–20 weeks), with particu lar loss of undif-
ferentiated OCT3/4pos cells. We found a 
similar period of sensitivity to DBP-exposure 
in the rat (i.e., E13.5–E15.5) (Figure 7A).
Discussion
Concerns about the potential human health 
effects of phthalates such as DEHP and DBP 
have been tempered by the demonstration 
that—unlike the fetal rat testis—the human 
fetal testis appears to be insensitive to the 
anti steroidogenic effects of DBP in a range 
of model systems (Albert and Jégou 2014; 
Heger et al. 2012; Lambrot et al. 2009; 
Mitchell et al. 2012; Spade et al. 2014). In 
contrast, the available evidence suggests that 
these same phthalates may adversely affect 
fetal germ cells in both rodents (Ferrara 
et al. 2006; Jobling et al. 2011) and humans 
(Heger et al. 2012; Lehraiki et al. 2009; 
Muczynski et al. 2012), although the under-
lying mechanisms are unexplored. In the 
present study, we sought to address these 
deficiencies by comparing the effects of DBP 
exposure in vivo on germ cells in the fetal 
rat testis with its effects on germ cells in the 
human fetal testis in an established xeno graft 
model. Our findings identify periods of germ 
cell sensitivity to the effects of DBP exposure 
in the rat (E13.5–E15.5) and human fetal 
testis (14–20 weeks of gestation). In rats, this 
coincides with the period when germ cells are 
undifferentiated (OCT3/4pos). In humans, 
differentiation of germ cells from OCT3/4pos 
to MAGE-A4pos occurs asynchronously over 
an extended period from the first trimester 
to early postnatal life, resulting in a hetero-
geneous population of germ cells at any given 
age during fetal development (Mitchell et al. 
2008). The predeliction for DBP-induced 
loss of OCT3/4pos germ cells may indicate a 
sensitive stage of differentiation rather than 
gestational age, and this requires further 
clarification; specifically, there may be more 
marked effects in earlier gestation when 
more of the germ cells are undifferentiated. 
In contrast, the develop ment of germ cell 
aggregation and/or MNGs was confined to 
differentiated germ cells in both fetal rats and 
humans, although aggregation appears to be 
a rare occurrence in the human compared 
with the rat. We also observed that the under-
lying mechanism for DBP-induced germ cell 
aggregation is probably a loss of Sertoli–germ 
cell membrane interaction, potentially due to 
micro filament redistribution within Sertoli 
cells. These findings provide new insights into 
the potential human testicular effects of fetal 
phthalate exposure.
The key finding of our study is that 
exposure of mice bearing human fetal testis 
xenografts to a high dose of DBP resulted in 
a small loss of germ cells, affecting undiffer-
entiated (OCT3/4 expressing) fetal germ cells 
in particular. Because the undifferentiated, 
rather than the differentiated, germ cells are 
highly proliferative (present study; Mitchell 
et al. 2010, 2014) and because undifferenti-
ated germ cells are present throughout human 
Figure 6. Effects of exposure to vehicle (A,C) or DBP (500 mg/kg/day; B,D) on the proliferation (Ki67; 
green) of undifferentiated (OCT3/4; red) and differentiated (MAGE-A4; blue) germ cell subpopulations in 
human fetal testis xenografts. (C) and (D) are higher magnifications of areas in (A) and (B), respectively. 
Arrowheads indicate examples of proliferating germ cells expressing OCT3/4; arrows indicate differenti-
ated germ cells positive for MAGE-A4 but negative for OCT3/4 and Ki67 immunostaining. (E) Percentage of 
OCT3/4pos or MAGE-A4pos germ cells expressing Ki67; no significant differences were found after exposure 
to DBP. Values shown are mean ± SE for 7 fetuses per treatment. Bars = 200 μm (A,B) and 50 μm (C,D). 
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gestation (Mitchell et al. 2010), it is possible 
that protracted fetal DBP exposure may 
cause progressive germ cell depletion in the 
human fetal testis. Similarly, MEHP exposure 
in vitro causes apoptotic germ cell loss in 
human fetal testis explants (Lambrot et al. 
2009; Muczynski et al. 2012). In our xeno-
graft experiments, we have not investigated 
the dose dependence of the germ cell changes 
induced by DBP because of the limited supply 
of human tissue, but it remains an impor-
tant issue in terms of risk evaluation for the 
human fetus. In this regard, we emphasize 
that in the experiments presented here, we 
used a dose of DBP (500 mg/kg/day) that is 
approximately 30,000 times higher than the 
reported exposure levels for women from the 
general population (Heudorf et al. 2007). In 
addition, it is possible that undifferentiated 
germ cells that survive DBP exposure might 
be affected in other ways; notably, undiffer-
entiated fetal germ cells are thought to give 
rise to carcinoma in situ cells in humans, from 
which testicular germ cell tumors develop in 
adulthood (Rajpert-De Meyts 2006). The 
OCT3/4pos/MAGE-A4neg population of 
undifferentiated germ cells has subsequent 
invasive potential (Mitchell et al. 2014), 
and this is an important avenue for further 
study. Overall, our findings show that DBP 
effects on fetal germ cells in the human are 
less pronounced than in the rat at the same 
dose, but the similarity of the types of effect 
observed with those in the rat suggest that the 
rat may represent a suitable model for evalu-
ating mechanisms of DBP-induced germ cell 
effects relevant to the human.
In the fetal rat, induction of MNGs 
(Fisher et al. 2003; Kleymenova et al. 2005; 
Mylchreest et al. 2002) and abnormal germ 
cell aggregation are also consequences of DBP 
exposure, and as indicated in the present 
study and by previous studies (Ferrara et al. 
2006; Jobling et al. 2011), these effects are 
confined to differentiated germ cells. We 
postulate that the formation of MNGs may 
reflect a failure to maintain cytoplasmic inter-
cellular bridges. Moreover, in the present 
study, germ cell aggregation was induced by 
DBP in a dose-dependent manner, even with 
relatively low doses (20 mg/kg/day). DBP 
induction of germ cell aggregation was an 
infrequent occurrence in human fetal testis 
xenografts, but, as in the rat, it was confined 
to differen tiated (MAGE-A4pos) germ cells. 
Of the seven fetal testes exposed to DBP after 
xenografting, germ cell aggregates were found 
in only 4 of 54 xenografts, all of which were 
derived from a single 19-week fetus. Because 
undifferentiated and differentiated germ cells 
are intermixed in the human and there is no 
defined “early” or “late” period in terms of 
germ cell differen tiation, it may be that induc-
tion of aggregation in the human is simply less 
possible, as opposed to the rodent fetal testes 
where germ cell differen tiation occurs synchro-
nously (McKinnell et al. 2013; Mitchell et al. 
2010). Because DBP induction of MNGs in 
rodents coincides with induction of germ cell 
aggregation, it may be that the under lying 
cause is the same. In this respect, the present 
study as well as previous studies using human 
fetal testis xenografts (Heger et al. 2012) or 
in vitro cultures (Lehraiki et al. 2009) have 
shown phthalate  induction of MNGs.
The present findings extend previous 
observations by providing more direct 
evidence that DBP-induced germ cell aggrega-
tion results from dissolution of Sertoli–germ 
cell membrane cross-linking (via espin–APC), 
which in turn may result from the redistri-
bution of microfilaments, such as vimentin 
and N-cadherin. APC, espin, N-cadherin, and 
vimentin have established roles in Sertoli–
germ cell interactions (Bartles et al. 1996; 
Chen et al. 1999; Kleymenova et al. 2005; 
Strelkov et al. 2003; Tanwar et al. 2011; Vogl 
et al. 2008). In the present study, expres-
sion of APC and espin was colocalized at the 
Sertoli–germ cell borders in E17.5 and E21.5 
control testes, whereas this colocalization was 
absent in DBP-exposed testes. Furthermore, 
immuno staining for the Sertoli cell filament 
markers N-cadherin and vimentin showed a 
collapse of the filament structures, with loss 
of Sertoli cell cytoplasmic “fingers” extending 
toward the center of the seminiferous cords 
in DBP-exposed rats at all ages. This altered 
pattern of vimentin staining following DBP 
exposure in E21.5 fetal rat testes is similar 
to that previously described by Kleymenova 
et al. (2005). Interestingly, the DBP-exposed 
human fetal testis xenografts that exhibited 
germ cell aggregation also showed an altered 
staining pattern for N-cadherin and APC 
similar to that in the rat, with a lack of Sertoli 
cell cytoplasmic “fingers” extending around 
the germ cells and loss of N-cadherin-APC 
interaction at the membrane level (espin could 
not be studied in the human). The present 
findings therefore provide a basis for further 
studies to investigate the mechanism of 
DBP-induced germ cell aggregation.
Conclusions
Our results show that DBP exposure of 
human fetal testis xenografts results in similar, 
although more muted, germ cell effects seen 
in the rat, namely, germ cell loss during fetal 
life with a predominant loss of undifferentiated 
(OCT3/4pos) germ cells, induction of MNGs, 
and (infrequent) germ cell aggregation, the 
latter two effects being confined to differen-
tiated germ cells in both species. Moreover, 
our results suggest similar DBP-induced loss 
of Sertoli–germ cell membrane contact among 
differen tiated germ cells. In view of these 
overall similarities, we suggest that the rat may 
be an appropriate model in which to study the 
mechanisms under lying DBP effects on germ 
cells. Whether fetal germ cell effects would 
occur in human fetal testes at population-
relevant DBP exposure levels remains to 
be explored.
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